Hemophilia A Treatment Race: Will siRNA and Gene Therapy Take the Lead? The hemophilia A therapeutic sector has experienced profound evolution through Hemlibra, which continues establishing innovative benchmarks in subcutaneous prophylactic delivery systems. This breakthrough medication has transformed clinical practice standards through its revolutionary mechanism of action and superior patient convenience factors. Financial forecasting...